FDA Approvals and Breakthroughs in COVID, Cancer, Malaria & More Vaccines

The FDA has approved Moderna’s next-gen COVID vaccine, mNexspike, for seniors and high-risk groups, amid contract cuts and CDC guideline changes. Curevo launched a 640-person Phase 2 shingles vaccine trial, comparing amezosvatein to Shingrix. Anixa completed Phase 1 of its breast cancer vaccine with promising immune responses. OSE’s Tedopi showed 65% one-year survival in pancreatic cancer. Sanaria’s malaria vaccine moves to pediatric trials in Burkina Faso. Lastly, Canid raised $10M to expand its AI-based pediatric vaccine management across 12 U.S. states.

Видео FDA Approvals and Breakthroughs in COVID, Cancer, Malaria & More Vaccines канала LucidQuest